Nyxoah joins Euronext Tech Leaders Initiative, included in Euronext Tech Leaders Index

Nyxoah joins Euronext Tech Leaders Initiative, included in Euronext Tech Leaders Index

Mont-Saint-Guibert, Belgium – 7 June 2022. 22:30 CET / 16:30 ET – Nyxoah SA (Euronext Brussels / Nasdaq: NYXH) (“Nyxoah” or “Company”) operates in the medical technology sector and focuses on the development and commercialization of innovative solutions for the treatment of obstructive sleep apnea syndrome (OSAS). The company is proud to announce that it is part of the new Euronext Tech Leaders initiative, which consists of more than 100 high-growth innovation and technology companies with more than € 1,000 billion in global market capitalization.

Companies participating in the Euronext Tech Leaders initiative will be included in the Euronext Tech Leaders index and will benefit from a range of exclusive programs, such as dedicated Euronext programs aimed at improving trading conditions for retail investors, high international visibility through marketing and communication initiatives and access. A C-level club that offers exclusive networking events.

“We are proud that our patient-focused mission has resulted in Nyxoah being one of the top 100 technology companies recognized for their innovation and growth through their involvement in the Euronext Tech Leaders initiative and index,” said Olivier Taelman, Nyxoah CEO. a.

About Nyxoah
Nyxoah operates in the medical technology sector. It focuses on the development and commercialization of innovative solutions for the treatment of obstructive sleep apnea syndrome (OSAS). Nyxoah’s main solution is the Genio system®, a CE-marked, patient-centered therapy for neurostimulation of the hypoglossal nerve, aimed at treating the patient for the treatment of obstructive sleep apnea syndrome (OSAS), the most common sleep-disordered breathing disorder in the world. The latter is associated with an increased risk of mortality and comorbidities, including cardiovascular disease. Nyxoah’s vision is that patients with OSA should be able to enjoy peaceful nights and live life to the fullest.

Upon successful completion of the BLAST OSA study, Genio System® received the European CE mark in 2019. Nyxoah successfully completed two IPOs: one at Euronext Brussels in September 2020 and the other at NASDAQ in July 2021. Thanks to the positive results of the BETTER SLEEP study, Nyxoah received the CE mark to extend its therapeutic indication for patients suffering of complete concentric collapse (CCC), for which competing therapies are currently contraindicated. In addition, the company is currently conducting a key IDE DREAM study for the FDA to obtain a marketing authorization.

For more information, visit the website http://www.nyxoah.com/.

attention – CE mark from 2019. American research device. Restricted to experimental use in the United States by U.S. federal law.

Loic Moreau, CFO
+32 473 33 19 80

Jeremy Feffer, vice president of R&D and corporate communications
+1 917 749 1494

MEDIA CONTACTS – mediateam@euronext.com
Aurelie Cohen (Europe)
+33 1 70 48 24 45

Marianne Aalders (Amsterdam)
+31 20 721 41 33

Pascal Brabant (Brussels)
+32 2 620 15 50

Sandra Machado (Lisbon)
+351 917 776 897

Andrea Monzani (Europe / Milan / Rome)
+39 02 72 42 62 13

Cathrine Lorvik Segerlund (Oslo)
+47 41 69 59 10

Sarah Mound (Paris)
+33 1 70 48 24 45

About Euronext
Euronext is a leading pan-European market infrastructure, linking European economies to global capital markets to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With nearly 2,000 listed issuers and a market capitalization of around € 6.6 trillion at the end of March 2022, it has an unrivaled blue chip franchise and a strong diversified national and international customer base. Euronext operates regulated and transparent capital and derivatives markets, one of Europe’s leading fixed-income e-commerce markets and the world’s largest debt and fund listing center. Its total product offering includes stocks, currencies, exchange traded funds, warrants and certificates, bonds, derivatives, commodities and indices. The Group provides a multi-asset clearing house through Euronext Clearing, as well as custody and settlement services through Euronext Securities’s central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in market management by providing technologies and managed services to third parties. In addition to its main regulated market, Euronext also manages a number of younger markets, simplifying list access for SMEs. For the latest news, visit euronext.com or follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

  • FRENCH_Euronext Tech Leaders PR_FINAL

Print Friendly, PDF & Email

Leave a Comment